Oppilotech have developed a unique high-resolution platform based on systems biology and machine learning to model biological processes in cells. The platform is utilized to identify first-in-class viable drug targets and to develop novel modes of action drugs modulating the identified targets. Three first-in-class antibacterial drug targets and generated active chemical matter against 2 of them.
Applying High-Resolution Dynamic Modelling Platform to model pathways in mammalian cells implicated in cancer
Location: United Kingdom, England, London
Investors 1
| Date | Name | Website |
| - | o2h ventur... | o2hventure... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 30.03.2017 | CARB-X dishes out $48M in grants to antimicrobial startups | Launched in mid-2016, CARB-X stands for Combating Antibiotic Resistant Bacteria Biopharmaceutical Ac... | medcitynew... |
| - | CARB-X dishes out $48M in grants to antimicrobial startups | CARB-X is making it rain. The international antimicrobial consortium today announced grants totalin... | medcitynew... |